Success from the Low Back Pain Implementation Collaborative

A year after the members of the Low Back Pain Implementation Collaborative wrapped up their work on developing solutions to avoid wasteful care, many organizations have put that work into practice.

To better understand how collaboration can benefit the Alliance membership, we checked in with the participating organizations to learn what they had done to ensure high-quality acute low back pain care.

A gateway to unnecessary opioid prescriptions and wasteful, expensive imaging, the work these organizations are taking will go a long way to ensure individuals experiencing acute low back pain return to normal, healthy lives as soon as possible.

Alliance Members Take Action

Multicare analyzes the clinical and economic impact of using dapagliflozin to treat chronic kidney disease from the commercial payer perspective

Chronic Kidney Disease is exceedingly common, with as many as one in seven people living with the disease in the United States. As such, per-member-per-month costs have risen to treat this disease.

Staff from Multicare, including Michael Shannon, M.D., a member of the Alliance's Quality Improvement Committee, conducted a cost-offset model to better understand the impact of dapaglifozin, a drug used to treat CKD, heart failure, and type 2 diabetes.

According to the study, published in August in the Journal of Managed and Specialty Pharmacy, the drug reduced clinical events and associated costs over three years.

Dr. Shannon of Multicare was among the presenters in a webinar on addressing chronic kidney disease hosted by the Alliance last September.

Read the full study.

As respiratory illness seasons loom, vaccines can keep employees healthy

As flu season approaches and other respiratory viruses including COVID-19 continue to move through Washington, vaccines can keep employees healthy this fall.

By prioritizing vaccination, organizations signal their commitment to the health and safety of their employees.

In the past several weeks, as the Food and Drug Administration approved the latest COVID-19 vaccine boosters, available to adults and children, pharmacies and clinics have begun receiving doses of the 2024-2025 updated flu vaccine.

Now is the time to prioritize a message that vaccines are available and reduce the risk of serious illness.

Sexual Health Awareness Month | Improving Chlamydia Screenings in Washington State

As a state, Washington on average screens just 36% of commercially insured residents for chlamydia, an STI that can lead to other health complications when not properly treated.

The Alliance's Quality Improvement Committee created this material to help clinicians navigate improving the rate of chlamydia screenings in their practices.

View the full infographic.

Our members and supporters can be the best ambassadors for our work. If you know someone who would like to learn more about membership in the Alliance, contact Denise Giambalvo, Director of Member Engagement & Business Strategy, at dgiambalvo@wahealthalliance.org.

Share This Email